Generation and Characterization of hiPSC-Derived Vascularized-, Perfusable Cardiac Microtissues-on-Chip

被引:0
作者
Arslan, Ulgu [1 ]
van den Hil, Francijna E. [1 ]
Mummery, Christine L. [1 ]
Orlova, Valeria [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands
来源
CURRENT PROTOCOLS | 2024年 / 4卷 / 07期
基金
欧盟地平线“2020”;
关键词
cardiac microtissues; human induced pluripotent stem cells; vascularization; vessels-on-a-chip; DISEASE; CELLS; CARDIOMYOCYTE; ORGANOIDS;
D O I
10.1002/cpz1.1097
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the heart in vivo, vasculature forms a semi-permeable endothelial barrier for selective nutrient and (immune) cell delivery to the myocardium and removal of waste products. Crosstalk between the vasculature and the heart cells regulates homeostasis in health and disease. To model heart development and disease in vitro it is important that essential features of this crosstalk are captured. Cardiac organoid and microtissue models often integrate endothelial cells (ECs) to form microvascular networks inside the 3D structure. However, in static culture without perfusion, these networks may fail to show essential functionality. Here, we describe a protocol to generate an in vitro model of human induced pluripotent stem cell (hiPSC)-derived vascularized cardiac microtissues on a microfluidic organ-on-chip platform (VMToC) in which the blood vessels are perfusable. First, prevascularized cardiac microtissues (MT) are formed by combining hiPSC-derived cardiomyocytes, ECs, and cardiac fibroblasts in a pre-defined ratio. Next, these prevascularized MTs are integrated in the chips in a fibrin hydrogel containing additional vascular cells, which self-organize into tubular structures. The MTs become vascularized through anastomosis between the pre-existing microvasculature in the MT and the external vascular network. The VMToCs are then ready for downstream structural and functional assays and basic characterization. Using this protocol, cardiac MTs can be efficiently and robustly vascularized and perfused within 7 days. In vitro vascularized organoid and MT models have the potential to transition current 3D cardiac models to more physiologically relevant organ models that allow the role of the endothelial barrier in drug and inflammatory response to be investigated. (c) 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC.Basic Protocol: Generation of VMToCSupport Protocol 1: Functional Characterization of VMToCSupport Protocol 2: Structural Characterization of VMToC
引用
收藏
页数:26
相关论文
共 38 条
  • [1] Vascularized hiPSC-derived 3D cardiac microtissue on chip
    Arslan, Ulgu
    Brescia, Marcella
    Meraviglia, Viviana
    Nahon, Dennis M.
    van Helden, Ruben W. J.
    Stein, Jeroen M.
    van den Hil, Francijna E.
    van Meer, Berend J.
    Cuenca, Marc Vila
    Mummery, Christine L.
    Orlova, Valeria V.
    [J]. STEM CELL REPORTS, 2023, 18 (07): : 1394 - 1404
  • [2] 3D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids
    Beauchamp, Philippe
    Jackson, Christopher B.
    Ozhathil, Lijo Cherian
    Agarkova, Irina
    Galindo, Cristi L.
    Sawyer, Douglas B.
    Suter, Thomas M.
    Zuppinger, Christian
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [3] Coronary microvascular disease: the next frontier for Cardiovascular Research
    Berry, Colin
    Duncker, Dirk J.
    [J]. CARDIOVASCULAR RESEARCH, 2020, 116 (04) : 737 - 740
  • [4] In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed
    Bonanini, Flavio
    Kurek, Dorota
    Previdi, Sara
    Nicolas, Arnaud
    Hendriks, Delilah
    de Ruiter, Sander
    Meyer, Marine
    Cabrer, Maria Clapes
    Dinkelberg, Roelof
    Garcia, Silvia Bonilla
    Kramer, Bart
    Olivier, Thomas
    Hu, Huili
    Lopez-Iglesias, Carmen
    Schavemaker, Frederik
    Walinga, Erik
    Dutta, Devanjali
    Queiroz, Karla
    Domansky, Karel
    Ronden, Bob
    Joore, Jos
    Lanz, Henriette L.
    Peters, Peter J.
    Trietsch, Sebastiaan J.
    Clevers, Hans
    Vulto, Paul
    [J]. ANGIOGENESIS, 2022, 25 (04) : 455 - 470
  • [5] Engineered tissue vascularization and engraftment depends on host model
    Brady, Eileen L.
    Prado, Olivia
    Johansson, Fredrik
    Mitchell, Shannon N.
    Martinson, Amy M.
    Karbassi, Elaheh
    Reinecke, Hans
    Murry, Charles E.
    Davis, Jennifer
    Stevens, Kelly R.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
    Brandao, Karina O.
    Tabel, Viola A.
    Atsma, Douwe E.
    Mummery, Christine L.
    Davis, Richard P.
    [J]. DISEASE MODELS & MECHANISMS, 2017, 10 (09) : 1039 - 1059
  • [7] Cardiac endothelial-myocardial signaling: Its role in cardiac growth, contractile performance, and rhythmicity
    Brutsaert, DL
    [J]. PHYSIOLOGICAL REVIEWS, 2003, 83 (01) : 59 - 115
  • [8] Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]
  • [9] Engineering of human brain organoids with a functional vascular-like system
    Cakir, Bilal
    Xiang, Yangfei
    Tanaka, Yoshiaki
    Kural, Mehmet H.
    Parent, Maxime
    Kang, Young-Jin
    Chapeton, Kayley
    Patterson, Benjamin
    Yuan, Yifan
    He, Chang-Shun
    Raredon, Micha Sam B.
    Dengelegi, Jake
    Kim, Kun-Yong
    Sun, Pingnan
    Zhong, Mei
    Lee, Sangho
    Patra, Prabir
    Hyder, Fahmeed
    Niklason, Laura E.
    Lee, Sang-Hun
    Yoon, Young-Sup
    Park, In-Hyun
    [J]. NATURE METHODS, 2019, 16 (11) : 1169 - +
  • [10] Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells
    Campostrini, Giulia
    Meraviglia, Viviana
    Giacomelli, Elisa
    van Helden, Ruben W. J.
    Yiangou, Loukia
    Davis, Richard P.
    Bellin, Milena
    Orlova, Valeria V.
    Mummery, Christine L.
    [J]. NATURE PROTOCOLS, 2021, 16 (04) : 2213 - +